SCHEMBL28040112

SCHEMBL28040112

COC(=O)CCS(=O)(=O)NN

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.50
CA12 O43570 6/20 0.47
CA14 Q9ULX7 6/20 0.47
LMNA P02545 3/20 0.42
KDM4E B2RXH2 1/20 0.42
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
CA7 P43166 4/20 0.38
CA9 Q16790 4/20 0.38
CA2 P00918 2/20 0.37
HSD17B10 Q99714 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
MGAM O43451 1/20 0.36
GAA P10253 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
SLC1A1 P43005 1/20 0.34
CA1 P00915 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25827382 0.80 TSHR (0.52) TSHRCA12CA14LMNAKDM4E
SCHEMBL1621069 0.77 TSHR (0.55) TSHRCA12CA14LMNAKDM4E
SCHEMBL17620948 0.75 TSHR (0.46) TSHRCA12CA14LMNAKDM4E
SCHEMBL27872399 0.75 APEX1 (0.52) TSHRLMNAKDM4EKMT2AMEN1
SCHEMBL4374105 0.75 TSHR (0.57) TSHRCA12CA14LMNAKDM4E
SCHEMBL1968935 0.75 TSHR (0.57) TSHRCA12CA14LMNAKDM4E
SCHEMBL1736046 0.73 TSHR (0.55) TSHRCA12CA14LMNAKDM4E
SCHEMBL770916 0.73 TSHR (0.55) TSHRCA12CA14LMNAKDM4E
SCHEMBL17311936 0.73 APEX1 (0.33)
SCHEMBL11922841 0.73 TSHR (0.55) TSHRCA12CA14LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105008367-B It is used as the pyrrolo-triazine class compound of potassium channel inhibitors 百时美施贵宝公司 2017-08-29 CN disclosed
CN-105008367-A Pyrrolotriazines as potassium ion channel inhibitors BRISTOL MYERS SQUIBB CO 2015-10-28 CN disclosed